ITC Won't Review Decision In Biomolecular Patent Fight
The U.S. International Trade Commission has decided not to review an internal judge's finding that a California biotechnology company did not infringe claims in a Sartorius patent directed to studying biomolecular...To view the full article, register now.
Already a subscriber? Click here to view full article